XML 19 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements Of Operations And Comprehensive Income (Loss) - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Revenues:        
Total revenues $ 302.4 $ 183.5 $ 539.5 $ 321.9
Operating expenses:        
Cost of sales 2.4 1.6 4.5 2.7
Research and development 80.9 61.7 139.2 99.4
Acquired in-process research and development 46.0 5.0 46.0 118.1
Selling, general and administrative 96.5 80.8 214.3 168.3
Total operating expenses 225.8 149.1 404.0 388.5
Operating income (loss) 76.6 34.4 135.5 (66.6)
Other income (expense):        
Interest expense (8.3) (7.9) (16.5) (15.8)
Unrealized gain (loss) on equity securities 11.3 21.0 (5.2) 22.7
Investment income and other, net 3.6 4.6 8.3 9.2
Total other income (expense), net 6.6 17.7 (13.4) 16.1
Income (loss) before provision for income taxes 83.2 52.1 122.1 (50.5)
Provision for income taxes 3.6 0.8 5.1 0.3
Net income (loss) 79.6 51.3 117.0 (50.8)
Unrealized gain on debt securities available-for-sale, net of tax 6.0 0.9 3.2 2.6
Comprehensive income (loss) $ 85.6 $ 52.2 $ 120.2 $ (48.2)
Net income (loss) per share, basic (in USD per share) $ 0.86 $ 0.56 $ 1.26 $ (0.56)
Net income (loss) per share, diluted (in USD per share) $ 0.81 $ 0.54 $ 1.20 $ (0.56)
Weighted average common shares outstanding, basic (in shares) 93.0 91.4 92.8 91.2
Weighted average common shares outstanding, diluted (in shares) 98.2 94.8 97.6 91.2
Product sales, net        
Revenues:        
Total revenues $ 267.6 $ 180.5 $ 498.7 $ 316.9
Collaboration revenue        
Revenues:        
Total revenues $ 34.8 $ 3.0 $ 40.8 $ 5.0